RBC Capital upgraded IGM Biosciences to Outperform from Sector Perform with a price target of $21, up from $9.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on IGMS: